Budefort Inhalation Capsule 400 mcg+12 mcg is a high-strength combination therapy containing Budesonide and Formoterol Fumarate, developed for the long-term management of moderate to severe asthma and chronic obstructive pulmonary disease (COPD). By combining an inhaled corticosteroid with a long-acting beta₂-agonist, Budefort targets both the underlying inflammation and bronchoconstriction associated with chronic respiratory diseases, providing enhanced symptom control, improved lung function, and reduced risk of exacerbations.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

Each inhalation capsule contains:

• Budesonide 400 mcg

• Formoterol Fumarate 12 mcg

Therapeutic Class

• Inhaled corticosteroid (ICS)

• Long-acting beta₂-adrenergic agonist (LABA)

• Bronchodilator and anti-inflammatory agent

Pharmacology and Mechanism of Action

Budesonide is a potent inhaled corticosteroid that reduces airway inflammation by inhibiting multiple inflammatory pathways, decreasing edema, mucus secretion, and hyperresponsiveness of the bronchial airways. Regular use helps prevent asthma attacks and COPD exacerbations.

Formoterol Fumarate is a selective long-acting beta₂-adrenergic receptor agonist that relaxes bronchial smooth muscle, leading to sustained bronchodilation. It has a rapid onset of action and provides long-term airflow improvement, making it ideal for maintenance therapy.

The combination of these two agents provides a dual mechanism: anti-inflammatory effects from budesonide and long-lasting bronchodilation from formoterol. This synergistic action helps control symptoms, improves breathing, and reduces the frequency of flare-ups in patients with chronic respiratory conditions.

Indications

Budefort Inhalation Capsule 400 mcg+12 mcg is indicated for:

• Long-term maintenance treatment of moderate to severe asthma in adults and adolescents

• Management of chronic obstructive pulmonary disease (COPD)

• Reduction of exacerbations in asthma and COPD

• Improvement in lung function, exercise tolerance, and quality of life for patients with persistent respiratory symptoms

Important: This inhalation capsule is not intended for acute relief of sudden asthma or COPD attacks.

Dosage and Administration

Budefort Inhalation Capsule is for inhalation use only and should be used with a compatible dry powder inhaler device. The usual recommended dose is one capsule inhaled twice daily, or as prescribed by a healthcare professional. Proper inhalation technique is critical to ensure maximum drug delivery to the lungs.

Patients are advised to rinse their mouth after inhalation to reduce the risk of oral candidiasis and maintain oral hygiene.

Benefits

• Effective long-term control of asthma and COPD symptoms

• Reduces airway inflammation and prevents disease exacerbations

• Provides sustained bronchodilation for improved airflow and breathing

• Convenient twice-daily dosing improves treatment adherence

• Enhances patient quality of life with better symptom management

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Precautions and Warnings

• Not suitable for acute relief of sudden bronchospasm

• Use with caution in patients with cardiovascular disease, infections, or hypersensitivity

• Rinse mouth after use to prevent oral fungal infections

• Do not exceed the prescribed dosage

• Use during pregnancy and lactation only if clearly advised by a healthcare professional

Storage

Store below 30°C in a dry place. Protect from moisture and direct sunlight. Keep out of reach of children.